ArticleJournal for immunotherapy of cancer2021

Incidence of immune checkpoint inhibitor-mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score-matched retrospective study.

Joseph Sleiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.